Adaptive Biotechnologies ADPT
NASDAQ ADPT
$24.42 +0.47 (+1.96%)
As of: Oct 20, 2026 · 3:59 PM EDT

Adaptive Biotechnologies (ADPT) EV to CFO (2019)

Updated

Adaptive Biotechnologies' (ADPT) EV to CFO came in at 7.27 for Q4 2019, down 49.6% from the prior quarter.

Analysis

Adaptive Biotechnologies (ADPT) EV to CFO (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 102.50 Bn 98.51 Bn -
2 Natera 58.05 Bn 53.74 Bn 485.19 Mn
3 Labcorp Holdings 26.39 Bn 24.13 Bn 1.11 Bn
4 Quest Diagnostics 26.28 Bn 24.41 Bn 1.03 Bn
5 Tenet Healthcare 22.71 Bn 11.72 Bn -
6 Guardant Health 21.59 Bn 17.65 Bn 219.03 Mn
7 BrightSpring Health Services 12.87 Bn 11.21 Bn 492.75 Mn
8 Fresenius Medical Care AG 12.49 Bn 4.44 Bn 1.52 Bn
9 Encompass Health 12.04 Bn 11.70 Bn -
10 Adaptive Biotechnologies 3.91 Bn 2.90 Bn 51.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 7.27
Sep 30, 2019 14.41
Jun 30, 2019 0.89
API Access

Adaptive Biotechnologies EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ADPT&period=max&api_key=YOUR_API_KEY